Register Login
Register to leave comments
  • News bot May 7, 2026, 9:01 p.m.

    📋 NEKTAR THERAPEUTICS (NKTR) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:30:58

    Event Type: Financial Results

    Event Details:

    NEKTAR THERAPEUTICS (NKTR) Reports the reporting period Financial Results NEKTAR THERAPEUTICS (NKTR) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (7,942
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 149578
      • 8 million of shares of its common stock, including the exercise in full by the underwriters of their option to purchase additional shares of common stock. ●In April, Nektar announced topline results from the 16
      • week blinded treatment extension of REZOLVE
      • AA, demonstrating deepening of responses in severe

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Other Assets 11.24K 14.14K $-2.90K -20.53%
    Current Liabilities Accounts Payable 10.03K 10.77K $-744.00 -6.91%
    Current Liabilities Other Long Term Liabilities 8.45K 8.62K $-179.00 -2.08%
    Operating Costs And Expenses Restructuring Impairment 796.00 169.00 $627.00 +371.01%
    Operating Costs And Expenses Total Operating Expenses 49.91K 54.99K $-5.08K -9.24%
    Operating Costs And Expenses Loss From Operations 39.05K 44.53K $-5.48K -12.31%
    Nonoperating Income Expense Interest Income 4.24K 2.87K $1.37K +47.60%
    Nonoperating Income Expense Total Other Income Expense 336.00 266.00 $70.00 +26.32%
    Nonoperating Income Expense Net Loss 44.90K 50.88K $-5.98K -11.75%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEKTAR THERAPEUTICS
    • Ticker Symbol: NKTR

Search

News categories